1. Home
  2. AAM vs GHRS Comparison

AAM vs GHRS Comparison

Compare AAM & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAM
  • GHRS
  • Stock Information
  • Founded
  • AAM 2024
  • GHRS 2018
  • Country
  • AAM United States
  • GHRS Ireland
  • Employees
  • AAM N/A
  • GHRS N/A
  • Industry
  • AAM
  • GHRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAM
  • GHRS Health Care
  • Exchange
  • AAM Nasdaq
  • GHRS Nasdaq
  • Market Cap
  • AAM 440.6M
  • GHRS 470.3M
  • IPO Year
  • AAM 2024
  • GHRS 2021
  • Fundamental
  • Price
  • AAM $10.05
  • GHRS $9.62
  • Analyst Decision
  • AAM
  • GHRS Strong Buy
  • Analyst Count
  • AAM 0
  • GHRS 3
  • Target Price
  • AAM N/A
  • GHRS $35.67
  • AVG Volume (30 Days)
  • AAM 95.8K
  • GHRS 71.7K
  • Earning Date
  • AAM 01-01-0001
  • GHRS 11-14-2024
  • Dividend Yield
  • AAM N/A
  • GHRS N/A
  • EPS Growth
  • AAM N/A
  • GHRS N/A
  • EPS
  • AAM N/A
  • GHRS N/A
  • Revenue
  • AAM N/A
  • GHRS N/A
  • Revenue This Year
  • AAM N/A
  • GHRS N/A
  • Revenue Next Year
  • AAM N/A
  • GHRS N/A
  • P/E Ratio
  • AAM N/A
  • GHRS N/A
  • Revenue Growth
  • AAM N/A
  • GHRS N/A
  • 52 Week Low
  • AAM $9,600.00
  • GHRS $5.05
  • 52 Week High
  • AAM $15,000.00
  • GHRS $14.99
  • Technical
  • Relative Strength Index (RSI)
  • AAM N/A
  • GHRS 58.95
  • Support Level
  • AAM N/A
  • GHRS $8.50
  • Resistance Level
  • AAM N/A
  • GHRS $11.09
  • Average True Range (ATR)
  • AAM 0.00
  • GHRS 0.90
  • MACD
  • AAM 0.00
  • GHRS 0.14
  • Stochastic Oscillator
  • AAM 0.00
  • GHRS 56.20

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

Share on Social Networks: